Evidence map›Paper›PMID 42377707›Full record

ArticleAIDS and behavior2026

Mpox Vaccine Hesitancy Among Sexually Active People with HIV in Care at Risk for mpox.

R J Fredericksen, L S Mixson, R M Nance, M Montaño, J A C Delaney, K H Mayer, S Safren, M O Johnson, K A Christopoulos, S A Ruderman and 12 more

Abstract read
PubMed Publisher
In one paragraph

Article in AIDS and behavior, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

R J FredericksenDepartment of Medicine, University of Washington, Seattle, WA, USA. rfrederi@uw.edu.ORCID http://orcid.org/0000-0003-3936-7048
L S MixsonDepartment of Medicine, University of Washington, Seattle, WA, USA.
R M NanceDepartment of Medicine, University of Washington, Seattle, WA, USA.
M MontañoDepartment of Global Health, University of Washington, Seattle, WA, USA.
J A C DelaneyDepartment of Medicine, University of Washington, Seattle, WA, USA.
K H MayerFenway Institute, Boston, MA, USA.
S SafrenDepartment of Psychology, University of Miami, Miami, FL, USA.
M O JohnsonDepartment of Medicine, University of California-San Francisco, San Francisco, USA.
K A ChristopoulosDepartment of Medicine, University of California-San Francisco, San Francisco, USA.
S A RudermanDepartment of Medicine, University of Washington, Seattle, WA, USA.
L N DrumrightDepartment of Medicine, University of Washington, Seattle, WA, USA.
C FaheyDepartment of Medicine, University of Washington, Seattle, WA, USA.
A RodriguezDepartment of Medicine, University of Miami, Miami, FL, USA.
S NapravnikDepartment of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
J J EronSchool of Medicine, University of North Carolina, Chapel Hill, NC, USA.
J KerulyDepartment of Medicine, Johns Hopkins University, Baltimore, MD, USA.
R D MooreDepartment of Medicine, Johns Hopkins University, Baltimore, MD, USA.
S L HeathDepartment of Medicine, University of Alabama, Birmingham, AL, UK.
M S SaagDepartment of Medicine, University of Alabama, Birmingham, AL, UK.
M M KitahataDepartment of Medicine, University of Washington, Seattle, WA, USA.
H M CraneDepartment of Medicine, University of Washington, Seattle, WA, USA.
A W HahnDepartment of Medicine, University of Washington, Seattle, WA, USA.

Funding

Virology CoreP30AI027767 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Paul A. Goepfert · 1988 to 2026
$84.1M
National Institute of Allergy and Infectious Diseases P30A10027757National Institute of Allergy and Infectious Diseases R24Ai067039National Institute of Drug Abuse R01DA047045National Institute of Drug Abuse R01DA058938National Institute of Drug Abuse U24DA058307NIAID NIH HHS P30 AI027767UW/Fred Hutchinson CFAR Developmental Core A1027757
6 · The paper itself

Abstract

Mpox has particularly adverse effects among people with HIV (PWH). We examined mpox vaccine utilization and hesitancy among men who have sex with men (MSM), and transgender women (TW) in HIV care in a multisite U.S. cohort. We queried MSM/TW reporting past 3-month sexual activity at 7 Centers for AIDS Research Network of Integrated Clinical Systems (CNICS) sites regarding mpox vaccination status, and willingness and hesitancy to vaccinate via questionnaires self-administered at routine HIV care visits between 1/2023 and 4/2024. We measured bivariate cross-sectional associations between vaccination status and demographic characteristics; among those reporting no vaccination, we measured associations between hesitancy and demographic characteristics. Among MSM/TW (n = 1146, mean age 46; 97% cisgender MSM, 3% TW; 46% white, 39% Black, 11% Hispanic), 52% (n = 597) reported not being vaccinated against mpox. Of these, 33% (n = 195) indicated they were not likely to be vaccinated despite provider recommendation. A higher proportion of Black respondents indicated they would not get vaccinated compared with white or Hispanic (42% vs. 23% and 33%, respectively; p ≤ 0.001). Key reasons were health concerns (57%, highest among Black participants, p ≤ 0.001), particularly concerns that 'not enough is known' about the vaccine (47%), side effects (25%), and low perceived acquisition risk (33%). Among sexually active MSM/TW in HIV care, mpox vaccine hesitancy was highest among persons of Black race. Common reasons were concerns about negative health effects, the belief that not enough is known about the vaccine, and low perceived risk. Education efforts should highlight mpox vaccine safety as well as mpox transmission risk.

Indexed as

Men who have sex with menMpoxPeople with HIVSexually transmitted infectionsTransgender womenVaccine hesitancy

Identifiers

PMID42377707

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.